If your concern is that it's present in breast milk, it seems pretty easy to address - feed the baby formula while the mother is taking the medication, and about a week after (I am not a doctor, this is not medical advice).
Presumably, that's why prescribing information says:
> The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for ZURZUVAE and any potential adverse effects on the breastfed child from ZURZUVAE or from the underlying maternal condition.
The benefits are presumably being weighed because they don't anticipate the mother breastfeeding the infant while she is on the medication.
Have you considered that perhaps they didn't test it on infants, not because they're a corrupt rubber stamp, but because there is no ethical way to do so? There is no possible benefit to the infant, but there is potential risk; that would violate the principle, "first, do no harm."
Why put children at risk when the problem is avoidable in the first place by not breastfeeding?
Presumably, that's why prescribing information says:
> The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for ZURZUVAE and any potential adverse effects on the breastfed child from ZURZUVAE or from the underlying maternal condition.
The benefits are presumably being weighed because they don't anticipate the mother breastfeeding the infant while she is on the medication.
Have you considered that perhaps they didn't test it on infants, not because they're a corrupt rubber stamp, but because there is no ethical way to do so? There is no possible benefit to the infant, but there is potential risk; that would violate the principle, "first, do no harm."
Why put children at risk when the problem is avoidable in the first place by not breastfeeding?